PHILADELPHIA--(BUSINESS WIRE)--Tolerance Bio, Inc., a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the ...

BASEL, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Granite Bio AG, a clinical-stage immunology company, has emerged from stealth with $100 million in funding. This includes a $30 million Series A ...

Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, ...

Bio-tar, once seen as a toxic waste, can be transformed into bio-carbon with applications in clean energy and environmental protection. This innovation could reduce emissions, create profits, and ...

NTx Bio, a leader in next-generation biomanufacturing technologies, today announced that Joan Haab, Ph.D., has been appointed ...

BIO-key International, Inc. will host its Q4 2024 investor call on March 27th at 10 a.m. ET, with results expected to be released earlier that morning. CEO Mike DePasquale and CFO Cecilia Welch will ...

Kimberly Dawn Neumann is a New York City-based magazine and book writer whose work has appeared in a wide variety of publications, including Women’s Health, Health, Cosmopolitan, Fitness, Prevention, ...